25 mg

DRUG9 trials

Sponsors

Universitair Medisch Centrum Groningen, Universitair Medisch Centrum Groningen, Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Hospices Civils De Lyon, Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy, Charite Universitaetsmedizin Berlin KöR

Conditions

COVID-19EndometriosisHerpes ZosterMenopauseOverpressureParkinsons DiseaseRenal TransplantationTreatment Resistant Depression (TRD)

Phase 2

CARPEUS : Effect of Carvedilol on the portosystemic gradient as measured by endoscopic ultrasound

RecruitingCTIS2024-518302-41-00

University Hospital Of Clermont-Ferrandcirrhotic portal hypertension

Start: 2025-04-16Target: 30Updated: 2025-08-25

COMPASS - COpenhagen MenoPAuSe Study

Not yet recruitingCTIS2025-522558-37-00

Region HovedstadenMenopause

Target: 200Updated: 2025-10-08

Phase 3

Prospective Randomized trial of Everolimus replacing MMF/MP Acid by the RECOVAC consortium to increase VACcine response in kidney transplant patients

CompletedCTIS2023-503894-39-00

Universitair Medisch Centrum Groningen, Universitair Medisch Centrum GroningenCOVID-19, Herpes Zoster, impaired immunity +1

Start: 2023-08-22End: 2024-02-27Target: 110Updated: 2023-10-10

Apa/Enza short study (Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-volume metastatic castration-sensitive prostate cancer: a randomized nationwide trial

RecruitingCTIS2023-506698-36-00

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)low-volume metastatic castration-sensitive prostate cancer

Start: 2024-02-02Target: 400Updated: 2025-12-03

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis: Randomised Prospective Study.

Not yet recruitingCTIS2024-519126-20-00

Hospital Fochadenomyosis, Endometriosis

Target: 180Updated: 2025-07-31

Optimal medical treatment of uncontrolled hypertension. OPTIMAL-HT

RecruitingCTIS2024-517628-20-00

Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczyhypertension, Overpressure

Start: 2023-10-24Target: 2500Updated: 2025-04-29

Dehydroepiandrosterone (DHEA) as augmentation of standard antidepressants in treatment-resistant depression: a randomized controlled trial (DARE-Trial) - A multicenter, randomized, double-blind, placebo-controlled trial with group sequential design

Not yet recruitingCTIS2024-517963-21-00

Charite Universitaetsmedizin Berlin KöRTreatment Resistant Depression (TRD)

Target: 320Updated: 2025-12-23

Phase 4

Efficiency of everolimus for the treatment of kidney transplanted patients presenting a missing self-induced NK-mediated rejection (STARR)

RecruitingCTIS2024-513814-37-00

Hospices Civils De LyonRenal Transplantation

Start: 2020-12-03Target: 20Updated: 2024-09-30

A multi-center, open label, longitudinal, observational, 12-week study of Flexilev treatment with the dosing device OraFID and accompanying digital app in Parkinson patients.

Not yet recruitingCTIS2025-524296-23-01

Navamedic ABParkinsons Disease

Target: 58Updated: 2026-02-24